Elmezzi Graduate School of Molecular Medicine

Manhasset, NY · official site ↗

Private nonprofitSpecial Focus: Medical Schools/CentersGraduate/Professional
Fin. Resilience
Resilience score

vs. 118 peers in its group

How is this calculated?

Elmezzi Graduate School of Molecular Medicine is a private nonprofit institution in Manhasset, NY, classified by Carnegie as “Special Focus: Medical Schools/Centers.”

It is benchmarked here against 118 peer institutions (Special Focus: Medical Schools/Centers · Private nonprofit).

Its strongest standing relative to peers is full-time faculty share (100%, 100th percentile).

Its weakest is metro-area unemployment rate (6.5%).

Peer group

Special Focus: Medical Schools/Centers · Private nonprofit

118 institutions

No cross-metric risk flags triggered.

How exposed Elmezzi Graduate School of Molecular Medicine is to the structural shifts reshaping higher ed: a composite structural-risk index plus the 2025 federal budget law’s endowment excise tax, Grad PLUS elimination, new Parent PLUS borrowing cap and new Workforce Pell short-term-credential opportunity, and the demographic enrollment cliff. Only signals that apply to this institution are shown.

Structural risk indexAn indicative 0–100 structural-risk index (higher = more pressure) blending operating margin, months of cash cushion, tuition dependency and the home-state enrollment cliff. Screens for the financial and demographic strain that precedes closures and mergers, directional, not a prediction.
50
Elevated
Enrollment cliff (home state)Projected change in the institution's home-state high-school graduates from 2025 to 2041 (WICHE). The U.S. total falls about 13%; a directional feeder-market signal, not an enrollment forecast.
-27%
Severe decline

Indicative signals, not forecasts, see each metric’s definition and the methodology. Endowment-tax, Grad PLUS, Parent PLUS and Workforce Pell figures appear only where the institution is actually exposed; “nationally” compares against all schools that report each signal.

Turn these signals into action

Seeing exposure is step one. Ibex builds AI agents that monitor and act on exactly these pressures, explore an interactive demo. Live demos run real workflows; the rest are working mockups we build to your institution’s data.

2.3
on a −4 to 10 scale
Financial Health IndexWatch

NACUBO Composite Financial Index, the balance-sheet health score accreditors and institutional boards use to gauge financial health; bond-rating agencies track similar ratios. 29th percentile of 118 peers. Carries little or no plant debt, so the viability ratio is excluded and weights re-normalized.

Primary reserve 55%0 mo
Return on net assets 30%5.1%
Operating result 15%17.2%

Composite of four ratios on a strength-factor scale (−4 weak → 10 strong): below 3 falls short of the threshold for financial health, below 1 signals acute stress, and above 6 is strong. Computed from IPEDS FY2022-23, the most recent finance release (it lags the current year by 2–3 years). Branch campuses that report finances at a parent/system level can show distorted ratios. For informational benchmarking, not a credit rating or financial advice.

Where the money comes from $4M total revenue · IPEDS FY2022-23

Private gifts & grants is the largest single source at 50% of revenue.

Private gifts & grants50.0%
Investment return50.0%

Where each dollar of revenue comes from, as a share of total positive revenue. Sources are standardized across public (GASB) and private (FASB) reporting; a net investment loss in a down market is shown as 0% and excluded from the mix.

Avg monthly faculty salaryAverage monthly salary of full-time faculty (IPEDS) – a proxy for faculty investment.
Strong
$19,293
99th percentile in peer grouppeer median $7,826
2024-25110 peers
Average monthly salary of full-time faculty, as reported to IPEDS.
Operating marginNet surplus as a share of total revenue, whether the institution runs in the black.
Strong
63.7%
98th percentile in peer grouppeer median 0.6%
FY2022-2391 peers
Net surplus as a share of total revenue (IPEDS FY2022-23): (total revenues − total expenses) ÷ total revenues. A surplus above 4% is strong; a thin surplus near 0% leaves little margin for shocks.
Tuition dependencyTuition's share of total revenue, how exposed the budget is to enrollment swings.
0%
1st percentile in peer grouppeer median 78.9%
FY2022-2391 peers
Tuition & fees as a share of total revenue (IPEDS FY2022-23). Higher = more exposed to enrollment swings.
State appropriations shareState appropriations' share of total revenue, material for public institutions, near zero for private.
0%
96th percentile in peer grouppeer median 0%
FY2022-2391 peers
State appropriations as a share of total revenue (IPEDS FY2022-23). Material for public institutions; ~0 for private.
Months of operating cushionMonths of operating expenses covered by expendable reserves, the institution's cash cushion.
Thin
0 mo
20th percentile in peer grouppeer median 9.9 mo
FY2022-2387 peers
How many months of operating expenses the institution could cover from expendable reserves (IPEDS FY2022-23 primary reserve ratio × 12). About 5 months, one semester, is the accreditor benchmark for solid footing; below ~3 months is thin. A negative figure means expendable reserves are themselves negative.
Return on net assetsChange in net assets over the year, whether the institution grew wealthier.
Strong
5.1%
72nd percentile in peer grouppeer median 1.4%
FY2022-2383 peers
Change in total net assets ÷ net assets (IPEDS FY2022-23) – whether the institution grew wealthier over the year. 2–4% is adequate; above 4% is strong.
Spent on instructionInstruction as a share of total functional expenses (private-nonprofit reporting).
0%
2nd percentile in peer grouppeer median 44.3%
2024-25109 peers
Instruction spending divided by total functional expenses (IPEDS Finance, FY2022-23 (FASB)). 'Where the money goes' context, reported here for private-nonprofit (FASB) institutions only, where the functional split is comparable; not computed for public or for-profit institutions. Higher is not automatically better; research universities and those with hospitals or large auxiliaries spread spending across other functions.
Spent on student servicesStudent services as a share of total functional expenses (private-nonprofit reporting).
0%
7th percentile in peer grouppeer median 9.6%
2024-25109 peers
Student-services spending (admissions, registrar, student life, counseling) divided by total functional expenses (IPEDS Finance, FY2022-23 (FASB)). Private-nonprofit (FASB) institutions only. Spending-mix context, not a quality measure.
Spent on academic supportAcademic support as a share of total functional expenses (private-nonprofit reporting).
0%
6th percentile in peer grouppeer median 8.5%
2024-25109 peers
Academic-support spending (libraries, academic computing, deans' offices) divided by total functional expenses (IPEDS Finance, FY2022-23 (FASB)). Private-nonprofit (FASB) institutions only. Context, not a quality measure.
Spent on researchResearch as a share of total functional expenses (private-nonprofit reporting).
0%
68th percentile in peer grouppeer median 0%
2024-25109 peers
Research spending divided by total functional expenses (IPEDS Finance, FY2022-23 (FASB)). Private-nonprofit (FASB) institutions only; near zero at teaching-focused colleges and sizeable at research universities. Spending-mix context, not a quality measure.
Structural risk indexAn indicative 0–100 structural-risk index (higher = more pressure) blending operating margin, months of cash cushion, tuition dependency and the home-state enrollment cliff. Screens for the financial and demographic strain that precedes closures and mergers, directional, not a prediction.
Elevated
50
2024-25
An indicative 0–100 structural-risk index (higher = more pressure), an equal-weight blend of the stress signals we measure: thin or negative operating margin, low months of operating cushion, high tuition dependency, and a shrinking home-state high-school-graduate pipeline (enrollment cliff). Averaged over whichever signals are available (at least two required). It screens for the financial and demographic pressures that precede closures and mergers, a directional indicator, NOT a prediction that any institution will close, and not a credit rating.
12-month FTE enrollmentFull-time-equivalent enrollment over the full year, the denominator for per-student finance measures.
9
1st percentile in peer grouppeer median 466
2022-23118 peers
Full-time-equivalent enrollment over the full 12-month year (IPEDS 12-month enrollment, 2022-23). Counts part-time students at their fractional load, so it runs above fall full-time headcount and is the denominator used for per-student finance measures.
Fully online studentsShare of students enrolled exclusively in distance-education (online) courses.
0%
35th percentile in peer grouppeer median 8%
2024-25118 peers
Share of students enrolled exclusively in distance-education courses (IPEDS, Fall 2023). Describes delivery model, not quality; online-heavy institutions look different on residential measures.
Applicant-pool diversity shiftProjected change in the non-white share of the home state's public high-school graduating class, class of 2025 to 2037.
+0.9%
WICHE 2024 (11th ed.)
Percentage-point change in the non-white share of the institution's home-state public high-school graduating class between the class of 2025 (the national peak) and 2037 (WICHE, Knocking at the College Door, 11th ed., public-school race detail). A forward look at who the future applicant pool will be: a positive value means the state's graduating class is projected to grow more racially diverse. Strategic recruiting context, not a forecast of any one school's enrollment, and a college recruits from many states.
Hybrid (some online) enrollmentShare of students enrolled in some but not all courses online (hybrid), Fall 2023.
0%
28th percentile in peer grouppeer median 29%
Fall 2023118 peers
Share of all students taking some, but not all, of their courses at a distance (IPEDS, Fall 2023). This is the hybrid middle ground between the fully online share and the fully in-person share, and it signals how far a school has moved coursework online without going exclusively remote. Context metric, not better or worse. Banded against the school's peer group.
Graduate share of enrollmentGraduate students as a share of total enrollment, Fall 2023.
100%
100th percentile in peer grouppeer median 64.1%
Fall 2023118 peers
Graduate students as a share of total headcount enrollment (IPEDS, Fall 2023). It separates research-intensive universities with large graduate bodies from undergraduate-focused institutions. Context metric, not better or worse. Banded against the school's peer group.
Direct competitors within 100 miNumber of same-type institutions (same Carnegie class and control) within 100 miles.
Below peers
6
75th percentile in peer grouppeer median 4
2024-25118 peers
How many institutions of the same type (same Carnegie classification and control, i.e. the schools competing for the same students) sit within roughly 100 miles. A higher count means a more crowded local market and a harder yield fight, which matters most as the regional pool of high school graduates shrinks; a low count means the school has its catchment largely to itself. Distance is straight-line from campus coordinates. Banded against the school's peer group. Fewer is better for recruiting leverage.
Metro-area unemployment rateUnemployment rate in the school's metro area, ACS 2019-23.
Below peers
6.5%
81st percentile in peer grouppeer median 5%
ACS 2019-23117 peers
The civilian unemployment rate in the school's metropolitan or micropolitan area (US Census ACS 2019-23, mapped by the school's federal CBSA code). It is a proxy for local labor demand: a lower rate means a tighter job market, a stronger near-term destination for graduates and a smaller pool of working adults to recruit. It describes the local economy, not the school. Schools outside any metro area are not scored. Banded against the school's peer group.
Enrollment cliff (home state)Projected change in the institution's home-state high-school graduates from 2025 to 2041 (WICHE). The U.S. total falls about 13%; a directional feeder-market signal, not an enrollment forecast.
Severe decline
-27%
2024-25
Projected change in the number of high-school graduates in the institution's HOME STATE from the class of 2025 (the national peak) to 2041, per WICHE's Knocking at the College Door, 11th Edition (Dec 2024). The 'enrollment cliff' is the post-2008 birth decline reaching college age; the U.S. total is projected to fall about 13% over this window. A college recruits from many states, so its home-state projection is an indicative directional signal of feeder-market pressure, not a forecast of that institution's own enrollment.
In-state HS graduatesPublic + private high-school graduates in the school's state, class of 2025.
206,184
79th percentile in peer grouppeer median 121,741
Class of 2025 (WICHE)109 peers
The size of the school's home-state high-school graduating class in 2025 (WICHE Knocking at the College Door, public and private combined). It is the near-term in-state feeder market, the complement to the enrollment-cliff projection, which shows the direction that market is heading. Context metric, not better or worse. Banded against the school's peer group.
Full-time faculty shareShare of faculty employed full-time, higher generally means more availability and continuity.
Strong
100%
100th percentile in peer grouppeer median 61.3%
2024-2599 peers

Elmezzi Graduate School of Molecular Medicine’s largest fields by completions, with graduate earnings (4 years out) and debt benchmarked against the same field at its peer group. Sparklines show the 8-year completions trend.

FieldCompletions / yrMedian earnings, 4 yrs outMedian debtEarnings premiumRisk score
Biological & Biomedical Sciences2High · 78

Earnings-premium status is an indicative estimate: median graduate earnings four years out vs the NY state median earnings of a high-school graduate (undergraduate credentials) or a bachelor’s-degree holder (graduate credentials) from the U.S. Census Bureau’s American Community Survey (2022 ACS 5-year). The official U.S. Department of Education determination uses its own cohort definition and may differ.

The risk score (0–100) is an indicative blend of earnings-premium margin and the five-year completions trend, higher means a field pays closer to (or below) the benchmark and is shrinking. A directional screen, not an official determination.

Major-level detail (CIP 4-digit)
Biological & Biomedical Sciences – 1 CIP program (4-digit), 0 with earnings
Major (CIP 4-digit)Compl./yrEarn 4yrEarn 1yr% > thresholdMedian debtDebt/earnEarnings premium2 of 3 yrs
Molecular MedicineCIP 26142

Major-level earnings, debt and threshold pass-rates are reported by College Scorecard only where enough graduates exist to protect privacy, so 0 of 1 major shows an earnings figure; the rest read “–”. % > threshold is ED’s own share of graduates out-earning the federal earnings threshold (the do-no-harm pass rate), drawn from the best available measurement window (4-, 5- or 1-year) pooled across all nine College Scorecard Field-of-Study releases; a small chip marks any figure not on the 4-year window, and hovering names the cohort size and source release. 2 of 3 yrs flags fields below the earnings-premium benchmark in two of the latest three reported cohort-years, the statutory trigger under the 2025 test (effective July 1, 2026). Indicative; the Department of Education’s official determination may differ. Source: U.S. Department of Education, College Scorecard Field of Study (2014–15 through 2022–23 cohorts + most-recent snapshot), accessed March 2026.

See the interactive dashboard for all fields and credential levels (associate through doctoral). Source: College Scorecard Field of Study.

How financially healthy is Elmezzi Graduate School of Molecular Medicine?
On the NACUBO Composite Financial Index, the −4 to 10 balance-sheet score accreditors and institutional boards use – Elmezzi Graduate School of Molecular Medicine scores 2.3 (Watch), computed from its IPEDS FY2022-23 finances. This is informational benchmarking, not a credit rating.
Which schools are Elmezzi Graduate School of Molecular Medicine's peers?
Elmezzi Graduate School of Molecular Medicine is benchmarked against 118 institutions in the Special Focus: Medical Schools/Centers · Private nonprofit peer group; all percentiles and medians on this page are computed within that group.

Explore Elmezzi Graduate School of Molecular Medicine interactively

Open the full dashboard to switch peer views, hover trends, and compare head-to-head.

Open in dashboard

Want a custom dashboard for Elmezzi Graduate School of Molecular Medicine?

We build tailored intelligence dashboards – Elmezzi Graduate School of Molecular Medicine and the peer set you choose, the metrics and risk signals your team cares about, kept current and delivered to you. Tell us what you’d want to track and a specialist will scope it with you.

Request a custom dashboard

Source: U.S. Department of Education, College Scorecard & IPEDS (most recent releases), with the U.S. Census Bureau (ACS), the U.S. Bureau of Labor Statistics (Employment Projections, field-demand outlook) and WICHE (enrollment-cliff projections). Figures lag the current academic year by roughly two to three years. Percentiles and medians are computed within the institution's peer group. Financial Resilience is a transparent composite, see each component above. Compiled by Ibex Insights.